))
Ep. 66 - Jane Grogan on Building Biogen’s Growth Engine
Manage episode 433170580 series 3571902
Innehåll tillhandahållet av BioCentury. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av BioCentury eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
As Jane Grogan anticipates the unmet needs in patients five years from now, she’s harnessing a wave of interest in targeting B cells as a key driver of an immunology expansion at Biogen. In conversation with Editor in Chief Simone Fishburn on The BioCentury Show, Grogan, who became EVP and head of research of Biogen in October, discusses how she’s approaching the mission to build diversity and balance the risk in the company’s portfolio, extending further into disease areas beyond neurology.
View full story: https://www.biocentury.com/article/653208
#RandD #DrugDevelopment #neurology #immunology #nephrology #celltherapy #bcells #CD28 #CD38
00:00 - Intro
01:05 – Expanding Research
08:22 – Integrating Hi-Bio
11:30 – Targeting B Cells
16:35 – Growing the Modality Toolbox
Kapitel
1. Ep. 66 - Jane Grogan on Building Biogen’s Growth Engine (00:00:00)
2. Expanding Research (00:01:05)
3. Integrating Hi-Bio (00:08:22)
4. Targeting B Cells (00:11:30)
5. Growing the Modality Toolbox (00:16:35)
17 episoder
Dela
